NFKB1 and neoplasm: Moreover, use of a Listeria-based hepatocellular carcinoma vaccine was found to activate and repolarize TAMs from M2 to M1 through activation of the NF-κB pathway via TLR2 and MyD88 pathways, ultimately resulting in a tumor-suppressive TME [210].